UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 424.7 EUR -0.56% Market Closed

Market Cap: €12B

U	United Therapeutics Corp XMUN:UTH	US
A	Alnylam Pharmaceuticals Inc XMUN:DUL	US
B	Basf Se DUS:BAS	DE
	UBS Group AG F:0UB	CH
L	L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA F:AILA	FR
H	Hikari Tsushin Inc XMUN:HIK	JP
S	Swatch Group AG XMUN:UHRN	CH

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

90% > 86%

Exceptional Operating Margin

44%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 44%

Exceptional Net Margin

42%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

41% > 42%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

34%

Free Cash Flow Margin is Increasing

32% > 34%

Positive ROE

19%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.